EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review

Matteo Val iD, Robert Delcanho, Marco Ferrari, Luca Guarda Nardini, Daniele Manfredini iD

Toxins · 01.09.2023 · 15 (9) · 541

DOI: 10.3390/toxins15090541 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Toxins, online erschienen am 01.09.2023. Verfasst von Matteo Val und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Technologies, School of Dental Medicine, University of Siena, 53100 Siena, Italy. Hauptthemen laut MEDLINE: Botulinum Toxins, Trigeminal Neuralgia, Neuralgia. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim of this paper is to provide a systematic review of the literature regarding the clinical use of botulinum toxin (BTX) to treat various orofacial neuropathic pain disorders (NP).

Methods

A comprehensive literature search was conducted using Medline, Web of Science, and the Cochrane Library databases. Only randomized clinical trials (RCT) published between 2003 and the end of June 2023, investigating the use of BTX to treat NP, were selected. PICO guidelines were used to select and tabulate the articles.

Results

A total of 6 RCTs were selected. Five articles used BTX injections to treat classical trigeminal neuralgia, and one to treat post-herpetic neuralgia. A total of 795 patients received BTX injections. The selected studies utilised different doses and methods of injections and doses. All the selected studies concluded superiority of BTX injections over placebo for reducing pain levels, and 5 out 6 of them highlighted an improvement in the patient’s quality of life. Most of the studies reported transient and mild side effects.

Conclusion

There is evidence of the efficacy of BTX injections in orofacial pain management. However, improved study protocols are required to provide direction for the clinical use of BTX to treat various orofacial neuropathic pain disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum ToxinsTrigeminal NeuralgiaNeuralgiaHumansFacial PainDatabases, Factual

Stichwörter der Autor:innen

botulinum toxin type Aessential trigeminal neuralgiaorofacial neuropathic disorderspainquality of life

Substanzen

Botulinum Toxins

Autor:innen und Institutionen

  • Department of Biomedical Technologies, School of Dental Medicine, University of Siena, 53100 Siena, Italy.
  • School of Dentistry, University of Western Australia, Perth 6009, Australia.
  • Unit of Oral and Maxillofacial Surgery, Ca'Foncello Hospital, 31100 Treviso, Italy.

ORCID-Profile: Matteo Val, Daniele Manfredini

Zitieren

APA

Val, M., Delcanho, R., Ferrari, M., Guarda Nardini, L., & Manfredini, D. (2023). Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review. Toxins, 15(9), 541. https://doi.org/10.3390/toxins15090541

Vancouver

Val M, Delcanho R, Ferrari M, Guarda Nardini L, Manfredini D. Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review. Toxins. 2023;15(9):541. doi:10.3390/toxins15090541

BibTeX
@article{Val2023,
  author = {Val, Matteo and Delcanho, Robert and Ferrari, Marco and Guarda Nardini, Luca and Manfredini, Daniele},
  title = {Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review},
  journal = {Toxins},
  year = {2023},
  volume = {15},
  number = {9},
  pages = {541},
  doi = {10.3390/toxins15090541}
}
Kostenlos starten →